Novartis Asks High Court To Restore Allergy Drug Patent
Novartis AG's Alcon Inc. unit on Friday urged the U.S. Supreme Court to reverse a Federal Circuit ruling that stripped patent protection for its allergy drug Pataday, arguing that the appeals...To view the full article, register now.
Already a subscriber? Click here to view full article